Notícias e Atividades da Fennec Pharma
Presença
Sede: Estados Unidos
Fennec Pharma é uma das ...
Fennec Pharma é uma empresa listada sob o símbolo FENC (US).
Executivos
Veja o organograma con seus 17 executivos principais
Biografias mais buscadas da Fennec Pharma
- Jeffrey Hackman, Chief Executive Officer and Director
- Khalid Islam, Chairman of the Board
- Jodi Cook, Director
Recentes movimentos de executivos em Fennec Pharma
- Rostislav Raykov, Director, se aposentou (Notícia publicada em 29 de abril de 2026).
Criar um alerta
para seguir os movimentos de executivos da Fennec Pharma.
Biotecnologia
Fennec Pharma possui 2.428 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).
Popular M&A news in Biotecnologia
- Eli Lilly has announced the acquisition of AtaiBeckley (publicado em 17 de julho de 2026).
- GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).
- Clearside Biomedical has gone out of its bankruptcy protection (publicado em 15 de julho de 2026).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Fennec Pharma
- Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | Fennec Pharmaceuticals Inc.
- Fennec Announces Results of Annual Meeting | Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting | Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update | Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026 | Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting | Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center | Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update | Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026 | Fennec Pharmaceuticals Inc.
- View more press releases Close
Redes sociais sobre Fennec Pharma
- Fennec Pharma na Wikipedia, Google News e Yahoo Finance
- Fennec Pharma na LinkedIn, X (Twitter) e YouTube
